O'Shaughnessy Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.4M Sell
2,136,557
-744,326
-26% -$19.5M 0.24% 82
2026
Q1
$80.9M Buy
2,880,883
+259,820
+10% +$6.92M 0.4% 41
2025
Q4
$65.3M Buy
2,621,063
+838,851
+47% +$21.2M 0.36% 48
2025
Q3
$45.4M Buy
1,782,212
+526,204
+42% +$13M 0.27% 68
2025
Q2
$30.4M Buy
1,256,008
+640,737
+104% +$14.9M 0.21% 95
2025
Q1
$15.6M Buy
615,271
+411,753
+202% +$10.8M 0.13% 190
2024
Q4
$5.4M Sell
203,518
-254,639
-56% -$6.91M 0.05% 386
2024
Q3
$13.3M Buy
458,157
+124,717
+37% +$3.64M 0.12% 196
2024
Q2
$9.33M Buy
333,440
+15,945
+5% +$439K 0.1% 235
2024
Q1
$8.81M Buy
317,495
+20,950
+7% +$581K 0.1% 243
2023
Q4
$8.54M Sell
296,545
-119,153
-29% -$3.6M 0.11% 203
2023
Q3
$13.8M Sell
415,698
-92,861
-18% -$3.28M 0.2% 122
2023
Q2
$18.7M Sell
508,559
-7,616
-1% -$296K 0.28% 96
2023
Q1
$21.1M Sell
516,175
-213,702
-29% -$9.23M 0.33% 80
2022
Q4
$37.4M Buy
729,877
+7,788
+1% +$373K 0.61% 36
2022
Q3
$31.6M Sell
722,089
-38,991
-5% -$1.89M 0.59% 40
2022
Q2
$39.9M Buy
761,080
+52,723
+7% +$2.69M 0.74% 28
2022
Q1
$36.7M Buy
708,357
+70,020
+11% +$3.63M 0.61% 37
2021
Q4
$37.7M Buy
638,337
+22,674
+4% +$1.12M 0.67% 35
2021
Q3
$26.5M Buy
615,663
+271,440
+79% +$12M 0.54% 52
2021
Q2
$13.5M Buy
344,223
+43,841
+15% +$1.7M 0.27% 104
2021
Q1
$10.9M Sell
300,382
-381,381
-56% -$13.5M 0.24% 104
2020
Q4
$25.1M Sell
681,763
-473,055
-41% -$17.4M 0.68% 40
2020
Q3
$40.2M Sell
1,154,818
-178,955
-13% -$6.27M 1.21% 24
2020
Q2
$41.4M Sell
1,333,773
-11,845
-0.9% -$402K 1.28% 23
2020
Q1
$41.7M Buy
1,345,618
+895,133
+199% +$30.5M 1.46% 20
2019
Q4
$16.7M Buy
450,485
+157,096
+54% +$5.6M 0.37% 68
2019
Q3
$10M Buy
293,389
+47,647
+19% +$1.73M 0.24% 84
2019
Q2
$10.1M Sell
245,742
-16,377
-6% -$650K 0.24% 81
2019
Q1
$10.6M Buy
262,119
+5,835
+2% +$234K 0.25% 75
2018
Q4
$10.6M Buy
256,284
+208,644
+438% +$8.66M 0.27% 68
2018
Q3
$1.99M Buy
47,640
+37,755
+382% +$1.45M 0.04% 189
2018
Q2
$338K Sell
9,885
-110,779
-92% -$3.79M 0.01% 411
2018
Q1
$4.06M Sell
120,664
-56,293
-32% -$1.94M 0.09% 138
2017
Q4
$6.08M Sell
176,957
-27,045
-13% -$922K 0.14% 116
2017
Q3
$6.91M Sell
204,002
-163,219
-44% -$5.25M 0.16% 94
2017
Q2
$11.7M Buy
367,221
+61,241
+20% +$1.93M 0.27% 73
2017
Q1
$9.93M Buy
305,980
+147,064
+93% +$4.64M 0.23% 73
2016
Q4
$9.02M Sell
158,916
-234,324
-60% -$7.15M 0.21% 84
2016
Q3
$12.6M Sell
393,240
-32,384
-8% -$1.08M 0.3% 72
2016
Q2
$14.2M Sell
425,624
-256,654
-38% -$8.19M 0.37% 71
2016
Q1
$19.5M Sell
682,278
-73,383
-10% -$2.1M 0.49% 59
2015
Q4
$23.1M Buy
755,661
+49,717
+7% +$1.56M 0.57% 48
2015
Q3
$21M Buy
705,944
+68,815
+11% +$2.21M 0.44% 57
2015
Q2
$20.3M Sell
637,129
-1,396,198
-69% -$45.5M 0.41% 63
2015
Q1
$67.1M Sell
2,033,327
-1,371,410
-40% -$43.6M 1.31% 24
2014
Q4
$100M Sell
3,404,737
-521,127
-13% -$14.9M 1.92% 7
2014
Q3
$110M Buy
3,925,864
+166,368
+4% +$4.67M 2.02% 9
2014
Q2
$106M Buy
3,759,496
+922,818
+33% +$26.3M 1.98% 9
2014
Q1
$86.4M Buy
2,836,678
+1,145,286
+68% +$34.1M 1.71% 14
2013
Q4
$49.1M Buy
1,691,392
+585,839
+53% +$17.1M 1.03% 31
2013
Q3
$30.1M Sell
1,105,553
-22,084
-2% -$601K 0.72% 42
2013
Q2
$30M Buy
+1,127,637
New +$31.2M 0.8% 33

Other funds holding PFE

O'Shaughnessy Asset Management's PFE Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Pfizer (PFE) stake by 26% in Q2 2026, selling an estimated $19.5M and leaving 2,136,557 shares worth $51.4M. The position accounts for 0.24% of the portfolio, ranked #82.

O'Shaughnessy Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $110M in Q3 2014. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • O'Shaughnessy Asset Management held 2,136,557 shares of Pfizer worth $51.4M as of Q2 2026.
  • O'Shaughnessy Asset Management sold 744,326 Pfizer shares in Q2 2026, an estimated $19.5M.
  • Pfizer made up 0.24% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #82 holding.
  • O'Shaughnessy Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • O'Shaughnessy Asset Management's Pfizer position peaked at $110M in Q3 2014.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.